159
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Practice of High-Flow Nasal Cannula Therapy in ARDS Patients: A Cross-Sectional Survey of Respiratory Therapists

ORCID Icon, ORCID Icon, ORCID Icon, , , , , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 1401-1411 | Received 15 Dec 2023, Accepted 06 Mar 2024, Published online: 26 Mar 2024

References

  • Park S. High-flow nasal cannula for respiratory failure in adult patients. Acute Crit Care. 2021;36(4):275–285. doi:10.4266/acc.2021.01571
  • Qaseem A, Etxeandia-Ikobaltzeta I, Fitterman N, Williams JW Jr, Kansagara D; Physicians CGCotACo. Appropriate use of high-flow nasal oxygen in hospitalized patients for initial or postextubation management of acute respiratory failure: a clinical guideline from the American College of Physicians. Ann Internal Med. 2021;174(7):977–984. doi:10.7326/M20-7533
  • Papazian L, Corley A, Hess D, et al. Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med. 2016;42(9):1336–1349. doi:10.1007/s00134-016-4277-8
  • Nishimura M. High-flow nasal cannula oxygen therapy devices. Respir Care. 2019;64(6):735–742. doi:10.4187/respcare.06718
  • Mauri T, Alban L, Turrini C, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med. 2017;43(10):1453–1463. doi:10.1007/s00134-017-4890-1
  • Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–1215. doi:10.1164/rccm.201605-0916OC
  • Gürün A, Öz M, Erol S, Çiftçi F, Çiledağ A, Kaya A. High flow nasal cannula in COVID-19: a literature review. Tuberk Toraks. 2020;68(2):168–174. doi:10.5578/tt.69807
  • Koyauchi T, Suzuki Y, Inoue Y, et al. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians. Respir Invest. 2022;60(6):779–786. doi:10.1016/j.resinv.2022.08.007
  • Sayan İ, Altınay M, Çınar AS, et al. Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia. Heart Lung. 2021;50(3):425–429. doi:10.1016/j.hrtlng.2021.02.009
  • Millar J, Lutton S, O’Connor P. The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure. Ther Adv Respir Dis. 2014;8(2):63–64. doi:10.1177/1753465814521890
  • Hernández G, Vaquero C, González P, et al. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA. 2016;315(13):1354–1361. doi:10.1001/jama.2016.2711
  • Alnajada A, Blackwood B, Messer B, Pavlov I, Shyamsundar M. International survey of high-flow nasal therapy use for respiratory failure in adult patients. J Clin Med. 2023;12(12):3911. doi:10.3390/jcm12123911
  • Puah SH, Li A, Cove ME, et al. High-flow nasal cannula therapy: a multicentred survey of the practices among physicians and respiratory therapists in Singapore. Aust Crit Care. 2022;35(5):520–526. doi:10.1016/j.aucc.2021.08.001
  • Alnajada A, Shyamsundar M, Messer B, Pavlov I. North American Survey of High-Flow Nasal Cannula Therapy Use. A42 ARF/ARDS. American Thoracic Society; 2022:A5535–A5535.
  • Besnier E, Hobeika S, NSeir S, et al. High-flow nasal cannula therapy: clinical practice in intensive care units. Ann Intens Care. 2019;9:1–8.
  • Li J, Tu M, Yang L, et al. Worldwide clinical practice of high-flow nasal cannula and concomitant aerosol therapy in the adult ICU setting. Respir Care. 2021;66(9):1416–1424. doi:10.4187/respcare.08996
  • Wen R, Hu X, Wei T, et al. High-flow nasal cannula: evaluation of the perceptions of various performance aspects among Chinese clinical staff and establishment of a multidimensional clinical evaluation system. Front Med. 2022;9:900958. doi:10.3389/fmed.2022.900958
  • Hosheh O, Edwards CT, Ramnarayan P. A nationwide survey on the use of heated humidified high flow oxygen therapy on the paediatric wards in the UK: current practice and research priorities. BMC Pediatr. 2020;20(1):109. doi:10.1186/s12887-020-1998-1
  • Abdelbaky AM, Elmasry WG, Awad AH, Khan S, Jarrahi M. The impact of high-flow nasal cannula therapy on acute respiratory distress syndrome patients: a systematic review. Cureus. 2023;15(6):1.
  • Lee CC, Mankodi D, Shaharyar S, et al. High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review. Respir Med. 2016;121:100–108. doi:10.1016/j.rmed.2016.11.004
  • Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device. Eur Respir Rev. 2017;26(145):170028. doi:10.1183/16000617.0028-2017
  • Vianello A, Arcaro G, Molena B, et al. High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection. Thorax. 2020;75(11):998–1000. doi:10.1136/thoraxjnl-2020-214993
  • Kang BJ, Koh Y, Lim C-M, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015;41(4):623–632. doi:10.1007/s00134-015-3693-5
  • O’Brien SL, Haskell L, Tavender EJ, et al. Factors influencing health professionals’ use of high-flow nasal cannula therapy for infants with bronchiolitis–A qualitative study. Front Pediatr. 2023;11:1098577. doi:10.3389/fped.2023.1098577
  • Jackson JA, Spilman SK, Kingery LK, et al. Implementation of high-flow nasal cannula therapy outside the intensive care setting. Respir Care. 2021;66(3):357–365. doi:10.4187/respcare.07960
  • Horvat CM, Pelletier JH. High-flow nasal cannula use and patient-centered outcomes for pediatric bronchiolitis. JAMA Network Open. 2021;4(10):e2130927–e2130927. doi:10.1001/jamanetworkopen.2021.30927